Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Is tandem ASCT needed in MM patients with high...
Conference

Is tandem ASCT needed in MM patients with high risk cytogenetics in the era of maintenance therapy? Results from the Canadian Myeloma Research Group (CMRG) Database.

Authors

Duggan P; McCurdy A; Louzada M; Leblanc M; Sebag M; Song K; Jimenez-Zepeda V; Kotb R; Masih-Khan E; Atenafu E

Name of conference

American Society of Hematology (ASH) Annual Meeting and Exposition - Virtual, ,

Conference place

Virtual

Conference start date

December 2, 2020

Conference end date

December 11, 2020